Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,172 | -21,397 | -16,215 | -9,590 | -3,838 |
| Depreciation Amortization | 60 | 235 | 175 | 115 | 56 |
| Accounts receivable | 2,063 | -1,406 | -262 | -1,496 | -995 |
| Accounts payable and accrued liabilities | -75 | -749 | 4,482 | N/A | -539 |
| Other Working Capital | 1,902 | -943 | 5,021 | -763 | -207 |
| Other Operating Activity | -483 | 5,727 | -1,550 | 3,389 | 2,535 |
| Operating Cash Flow | $-2,705 | $-18,533 | $-8,349 | $-8,345 | $-2,988 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -41 | -171 | -161 | -138 | -134 |
| Investing Cash Flow | $-41 | $-171 | $-161 | $-138 | $-134 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 197 | 6,942 | 1,595 | 325 | 303 |
| Other Financing Activity | -207 | -1,396 | -1,191 | -790 | -394 |
| Financing Cash Flow | $-10 | $5,546 | $404 | $-465 | $-91 |
| Exchange Rate Effect | 4 | -1 | -5 | -2 | 1 |
| Beginning Cash Position | 41,562 | 54,721 | 54,721 | 54,721 | 54,721 |
| End Cash Position | 38,810 | 41,562 | 46,610 | 45,771 | 51,509 |
| Net Cash Flow | $-2,752 | $-13,159 | $-8,111 | $-8,950 | $-3,212 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,705 | -18,533 | -8,349 | -8,345 | -2,988 |
| Capital Expenditure | -41 | -171 | -161 | -138 | -134 |
| Free Cash Flow | -2,746 | -18,704 | -8,510 | -8,483 | -3,122 |